BIOTECHNOLOGY VALUE FUND L P - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for 4D Molecular Therapeutics, Inc. (FDMT)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
FDMT
Shares outstanding
48.4M shares
Disclosed Ownership
4.83M shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 04:20 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 7.1% 3.45M 0 3.45M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 7.1% 3.45M 0 3.45M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 2.4% 1.12M 0 1.12M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 2.4% 1.12M 0 1.12M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.4% 204K 0 204K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.4% 204K 0 204K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.4% 4.57M 0 4.57M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 9.99% 4.83M 0 4.83M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 9.99% 4.83M 0 4.83M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 9.99% 4.83M 0 4.83M /s/ Mark N. Lampert Mark N. Lampert